Community/Retail

Chronic hypersensitivity pneumonitis is a long-term lung condition in which the interstitial tissue surrounding the alveoli of the lungs becomes inflamed and develops fibrosis.

Foot drop is a sign of an underlying neurological, muscular, or anatomical problem.

Trial court judge places limits on testimony of widow’s pharmacy expert witness and dismisses lawsuit.

Laura Lee Hall, PhD, president of the Center for Sustainable Health Care Quality and Equity (SHC), addresses what the SHC’s diabetes DRIVE toolkit is and how it helps to address disparities in diabetes disease burden and health outcomes.

Xanax is indicated for the acute treatment of generalized anxiety disorder and treatment of panic disorder with or without agoraphobia in adults.

Sarah Temkin, MD, of the Office of Research on Women’s Health (ORWH) at the National Institutes of Health (NIH), discusses how the NIH ORWH has helped to advance clinical research on biological and sociological variables.

Tea tree oil is indicated for everyday use associated with its cleansing properties.

Despite demonstrating numerous benefits, semaglutide has also been linked to an increased incidence of diabetic retinopathy, which was initially reported in the SUSTAIN-6 trial.

The health of a pharmacy business is under attack from many directions, but retail pharmacies can take steps to alleviate some of this pressure to improve the health of their business.

Common triggers for atrial fibrillation include alcohol, caffeine, and less sleep.

Flatfeet develop after an injury or from the simple wear-and-tear stresses of age.

The drug is the first and only oral therapy approved for the treatment of adult patients who are candidates for either phototherapy or systemic therapy.

Ronald T. Piervincenzi, PhD, CEO of US Pharmacopeia, explains how pharmacists and USP came together in 2021 to work harder than ever before, as well as what can be done now to prepare for the next health crisis.

Crestor is indicated for the treatment of patients with primary hyperlipidemia and mixed dyslipidemia.

TXNIP inhibition could prevent beta cell loss and protect beta cell function to potentially contribute to diabetes management and its complications.

Pharmacists play an important role in educating patients and other health care practitioners on the signs and symptoms of C. difficile infection.

Paying close attention to the pharmacy’s operational and financial success does not have to come at the expense of quality patient care.

Lotrimin is indicated for the treatment of several common skin infections, such as athlete's foot, jock itch, and ringworm.

Investigators found that an additional hour of sleep correlated with a 26% decrease in an infant’s risk of being overweight.

Terrasil Shingles Skincare helps to alleviate pain, itching, burning, and irritation associated with shingles.

Vraylar is an atypical antipsychotic indicated for the treatment of adult patients with schizophrenia and for manic, mixed, or depressive episodes for patients with bipolar I disorder.

Ronald T. Piervincenzi, PhD, CEO of US Pharmacopeia, discusses the challenges that lie ahead as we move into the third year of the COVID-19 pandemic, as well as other major developments on the horizon for pharmacists in 2022.

Prevalence of type 2 diabetes has been found higher in people with bipolar disorder, schizophrenia, and major depression compared to the general population.

Universal school-based depression screening shows promise addressing mental health conditions in students.

Cold sores are usually caused by herpes simplex virus type 1 and herpes simplex virus type 2.

Bevespi is indicated for the long-term, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease.

The Bruise Remedy gel contains a botanical formula to relieve and soothe bruising.

Ronald T. Piervincenzi, PhD, CEO of US Pharmacopeia, discusses what stands out as the biggest challenge from the past year and what role USP and pharmacists had in overcoming that challenge.

Luciano Costa, MD, PhD, associate director for clinical research at the O’Neal Comprehensive Cancer Center at the University of Alabama at Birmingham, on the safety and efficacy of Dara-KRd in the treatment of patients with newly diagnosed multiple myeloma.

The first and only orally disintegrating tablet form of glycopyrrolate, the product will be launched in early 2022.